Chapter 09 – Agency Conflicts and Corporate Governance
1
CHAPTER 9
Agency Conflicts and Corporate Governance
1. Aversion to sure loss, supported by excessive optimism and overconfidence, drove the
behavior of both Waksal and Stewart. Once both had advance knowledge of the decision by
the FDA regarding Erbitux, the reasonable expectation of a price drop in ImClone stock
2. Issuing new equity is like selling lottery tickets. Biotech stocks offer the small probability
3. HealthSouth’s interest to engage in fraud would naturally be in conflict with the interests
of its auditors. Therefore, the “pristine audit program” can be construed as a device to move